Vivo Bio Tech Ltd Share Price

Q: What is the share price of Vivo Bio Tech Ltd today?

Vivo Bio Tech Ltd share price as on 14 Jul 2026 is ₹23.5

Pharmaceuticals

BSE: 511509 Small Cap ISIN: INE380K01017

As on 14 July 2026 at 23:15 IST

₹23.50

+ 0.46

(2.00%)

Sell Buy

Over 1 Month

-18.50%

Over 6 Months

-21.28%

Over 1 Year

-39.70%

Over 3 Years

-21.31%

Vivo Bio Tech Ltd Summary

Close ₹23.04

Open ₹24.44

High ₹24.44

Low ₹23

Volume 20,044

Net Turnover (in Cr) ₹0.046

52Wk High ₹43.35

52Wk Low ₹20.35

52Wk High / Low

20.35

43.35

Vivo Bio Tech Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹51.13

EPS (TTM) -

Book Value (BV) 41.28

Div. Yield -

P/E (TTM) -26.48

Price/Book Value 0.56

Delivery % 70.61 %

Face Value 10

Key Ratios

PE Ratio 7.70

PB Ratio 0.82

EV to Sales 2.31

PEG Ratio 0.05

ROA 5.79

ROE 6.05

Debt-Equity 0.93

Net Profit Margin 8.59

Operating Profit Margin 45.08

Vivo Bio Tech Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	51.48	45.49	52.27	51.49	51.85
Total Expenses	42.68	41.43	47.65	47.02	43.23
Profit Before Tax	8.79	4.06	4.62	4.47	8.62
Profit After Tax	7.28	2.53	2.65	2.20	5.68
Operating Profit After Depreciation	16.30	11.84	12.27	8.47	12.15

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	88.24	80.37	88.87	95.17	52.05
Total Non Current Assets	101.29	89.90	91.24	96.45	52.44
Total Current Assets	41.94	47.23	31.79	26.03	27.09
Total Assets	143.23	137.13	123.03	122.49	79.52
Total Shareholder's Fund	77.90	54.40	51.87	47.13	42.53

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	11.83	15.52	14.83	16.64	14.18
Net Cash Used In Investing Activities	-15.84	-7.95	-4	-51.11	-22.82
Net Cash Used In Financing Activities	3.90	-7.56	-11.18	35.02	8.78

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	51.48	44.92	51.66	51.48	51.85
Total Expenses	42.40	40.86	47.05	47.01	43.23
Profit Before Tax	9.08	4.05	4.61	4.47	8.62
Profit After Tax	7.57	2.52	2.63	2.20	5.68
Operating Profit After Depreciation	16.59	11.83	12.26	8.47	12.15

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	84.88	77.01	85.51	91.81	48.69
Total Non Current Assets	97.97	86.58	87.92	93.12	49.10
Total Current Assets	43.31	48.22	32.88	27.18	28.21
Total Assets	141.29	134.80	120.81	120.30	77.31
Total Shareholder's Fund	78.19	54.40	51.87	47.14	42.54

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	11.83	15.83	14.73	16.43	14.10
Net Cash Used In Investing Activities	-15.84	-7.95	-4	-51.11	-22.82
Net Cash Used In Financing Activities	3.90	-7.56	-11.20	35.04	8.83

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	14.20	13.51	13.11	12.51	12.29
Total Expenses	9.75	8.02	7.70	7.03	7.27
Profit Before Tax	0.25	1.57	1.50	1.48	1.24
Profit After Tax	-5.16	1.25	0.87	1.34	1.06
Operating Profit after Depreciation	4.48	5.63	5.54	5.62	5.17

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	13.77	13.37	13.02	12.42	12.29
Total Expenses	9.59	7.86	7.60	6.90	7.15
Profit Before Tax	-0.02	1.59	1.51	1.52	1.36
Profit After Tax	-5.44	1.26	0.87	1.37	1.19
Operating Profit after Depreciation	4.21	5.65	5.55	5.66	5.29

Vivo Bio Tech Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 22.55

S2 22.05

S3 21.11

Pivot 23.49

R1 23.99

R2 24.93

R3 25.43

Moving Average

20 SMA 25.68

50 SMA 26.42

100 SMA 26.85

200 SMA 30.50

Vivo Bio Tech Ltd Corporate Actions

No available data

AGM Date: 28 Sep 2021

Please find attached outcome of the Board Meeting held on 28th August 2021. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed the summary of the proceedings of the 34th Annual General Meeting held on 28th September 2021. This is for your information and records. (As Per BSE Announcement Dated on 9/28/2021 8:08:14 AM) Please note that resolution Nos 1 to 7 in the Notice dated 28th August 2021 of the 34th Annual General Meeting (AGM) have been passed by the shareholders with requisite majority. Further pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith the voting results (Annexure-A) in the prescribed format in respect of the votes cast through remote e-voting and e-voting at the 34th Annual General Meeting of the Company held on 28th September 2021. A copy of the Scrutinizers Report is enclosed as Annexure-B. (As Per BSE Announcement Dated on 9/30/2021 7:54:40 AM)

AGM Date: 28 Sep 2022

AGM 28/09/2022 Vvo Bio Tech Limited has informed the exchange that the Board of Directors of the Company at their meeting held today, i.e. Tuesday, August 30, 2022, inter-alia, transacted and approved the following business: 1. The 35th Annual General Meeting of the Company will be held on Wednesday, September 28, 2022 at 03.00 p.m. through Video Conferencing / Other Audio Visual Means (VC/OAVM). 2. Fixation of the dates of Book Closure from Thursday, September 22, 2022 to Wednesday, September 28, 2022 (Both Days inclusive) for the purpose of the 35th Annual General Meeting. 3. The Board's Report for the financial year 2021-2022. 4. The E-voting schedule in connection with the 35th Annual General Meeting, Notice thereof and other related matters. Vivo Bio Tech Limited has informed the exchange that the book closure for the purpose of the ensuing 35th Annual General Meeting of the Company is from Thursday, September 22, 2022 to Wednesday, Septemebr 28, 2022 (both days inclusive). (As Per BSE Announcement Dated on 30/08/2022) Vivo Bio Tech Limited has submitted with the exchange the Voting Results and Scrutinizers Report for the resolutions passed by the members of the Company at the 35th Annual General Meeting held on September 28, 2022 through Video Conference. Vivo Bio Tech Limited has informed the exchange that the members of the Company have appointed M/s P Murali & Co (FRN 007257S), Chartered Accounts as the Statutory Auditors of the Company at the 35th Annual General Meeting of the Company held on September 28, 2022 through video conference. Vivo Bio Tech Limited has informed the exchange that the members of the Company have approved the resolution for shifting of registered office of the Company from Survey #349/A, Pregnapur Village, Gajwel, Siddipet District, Hyderabad, Telangana - 502311 to 03rd Floor, Ilyas Mohammed Khan Estate, #8-2-672/ 5 & 6, Road No.1, Banjara Hills, Hyderabad, Telangana - 500034, at the 35th Annual General Meeting of the Company held on September 28, 2022 through video conference. (As Per BSE Announcement Dated on 29/09/2022)

AGM Date: 30 Sep 2023

Vivo Bio Tech Limited has informed the exchange regarding the business items transacted and approved by the Board at its meeting held today i.e. on August 31, 2023 Vivo Bio Tech Limited has submitted with the exchange the Newspaper Advertisement for Notice of 36th Annual General Meeting of the Company (As Per BSE Announcement Dated on 09/09/2023) Vivo Bio Tech Limited has submitted with the exchange the Scrutinizers Report and Voting Reults for business transacted at the 36th Annual General Meeting of the Company held on September 30, 2023.

AGM Date: 30 Sep 2024

Please find enclosed Outcome of the Board Meeting Please find enclosed proceedings of the 37th Annual General Meeting (As per BSE Announcement dated on 30/09/2024) Please find enclosed Voting Results for the 37th Annual General Meeting (As Per BSE Announcement Dated on 01.10.2024)

AGM Date: 30 Sep 2025

The 38th Annual General Meeting (AGM) of the Company will be held on Tuesday, September 30, 2025 through Video Conferencing / Other Audio Visual Means (VC/OVAM). Newspaper publication for intimation of conducting 38th Annual General Meeting (As per BSE Announcement Dated on 04.09.2025) Proceedings/Outcome of the 38th Annual General Meeting of the company held on September 30, 2025 (As Per BSE Announcement Dated on: 30.09.2025) Please find enclosed (As Per BSE Announcement Dated on:01.10.2025)

Vivo Bio Tech Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Vivo Bio Tech Ltd Top Mutal Funds Invested

No data available

Vivo Bio Tech Ltd News

Vivo Bio Tech postpones board meeting

To 30 May 2026

28 May 2026, 02:39 pm

Vivo Bio Tech to hold board meeting

On 29 May 2026

26 May 2026, 01:59 pm

Vivo Bio Tech announces board meeting date

On 13 February 2026

02 Feb 2026, 04:07 pm

Vivo Bio Tech to hold board meeting

On 14 November 2025

05 Nov 2025, 12:37 pm

Vivo Bio Tech to convene AGM

On 30 September 2025

29 Aug 2025, 03:55 pm

Vivo Bio Tech Ltd Stock Analysis

Annual revenue for Vivo Bio Tech Ltd increased by 14.60% to ₹51.48 crore in FY 2025 from ₹44.92 crore in FY 2024.
Annual Net Profit for Vivo Bio Tech Ltd increased by 200.15% to ₹7.57 crore in FY 2025 from ₹2.52 crore in FY 2024.
Promoter Shareholding in Vivo Bio Tech Ltd increased by 0.75% in the most recent quarter, from 35.16% in December 2025 to 35.43% in March 2026.
Vivo Bio Tech Ltd delivered a 1-year return of -39.70% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Vivo Bio Tech Ltd share price moved up by 2.00% from its previous close of INR ₹23.04. The latest Vivo Bio Tech Ltd share price is INR ₹23.50.
Vivo Bio Tech Ltd share price today has been at a low of 23 and a high of 23.90. Over the past 52 weeks, the Vivo Bio Tech Ltd share price has seen a low of 20.35 and a high of 43.35.